Search
for
Sort by
Research 61–90 of 333
- Differential Association Between Cumulative Dose of 5α-Reductase Inhibitors and Mortality
- Association of 5α-Reductase Inhibitors with Depression and Suicide: A Mini Systematic Review and Meta-analysis
- Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia
- Chronic Exposure with 5‐Alpha Reductase Inhibitor Ameliorates Anxiety and Depression‐like Behaviors By Reducing Systemic Oxidative Stress in D‐galactose‐Induced Aging Male Rats
- Chronic Exposure of 5‐Alpha Reductase Inhibitor in Young Male Rats Induces Not Only Metabolic Disturbance, But Also Depressive‐Like Behaviors as Similar with Obese Condition
- Use of 5α-reductase inhibitors and survival of oesophageal and gastric cancer in a nationwide Swedish cohort study
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- MP85-05 SEXUAL DYSFUNCTION AFTER 5-ALPHA REDUCTASE INHIBITOR USE: INSIGHTS FROM THE REDUCE STUDY GROUP DATABASE
- 5ARI and PSA: open questions
- Review: Adding α<sub>1</sub>-blockers to 5α-reductase inhibitors improves lower urinary tract symptoms in men
- Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
- Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals
- Sponsored Lecture 3 : Updates on 5 alpha-rers(5ARIs) for the treatment of male pattern hair loss(MPHL)
- Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-Blockers vs 5-Alpha Reductase Inhibitors
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- 5-Alpha Reductase Inhibitors and Erectile Dysfunction: The Connection
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis
- Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Long-term Oral Administration of 5α-reductase Inhibitor Attenuates Erectile Function by Inhibiting Autophagy and Promoting Apoptosis of Smooth Muscle Cells in Corpus Cavernosum of Aged Rats
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- 5α-Reductase inhibitors in androgenetic alopecia